The World’s Five Deadliest Cancers: Current Trends, Therapeutics, and Future Directions

Cancer remains a leading cause of death worldwide, with breast, lung, colorectal, prostate, and cervical cancers contributing significantly to global cancer-related morbidity and mortality. While individual lethality varies among these cancers, their combined impact on public health is substantial due to high incidence and, in some cases, limited access to early detection and effective treatment. These malignancies arise from a complex interplay of genetic, hormonal, lifestyle, and infectious factors, with molecular mechanisms that inform targeted therapies and precision medicine approaches. Advances in screening, immunotherapy, AI-assisted diagnostics, and minimally invasive surgical techniques have improved outcomes; however, challenges such as late diagnosis, treatment resistance, and healthcare disparities persist, particularly in low- and middle-income countries. This review provides a comprehensive synthesis of the epidemiology, risk factors, molecular pathogenesis, clinical features, current treatment strategies, emerging technologies, public health implications, and future research directions for the five deadliest cancers. Emphasis is placed on preventive measures, early detection, and equitable access to care, highlighting strategies to reduce the global cancer burden and improve survival outcomes.